logo
Share SHARE
FONT-SIZE Plus   Neg

Twitter Obtains $1 Bln Credit Facility

Twitter Inc., which is readying for an initial public offering, obtained $1 billion credit facility this month, the social media company said in a regulatory filing.

The offering's lead underwriter Goldman Sachs Group Inc. (GS) is providing $150 million, while Morgan Stanley (MS) and JPMorgan Chase & Co. (JPM) are contributing $250 million each.

Other lenders include Bank of America Corp. (BAC) and Deutsche Bank AG (DB). The revolving unsecured credit facility matures in 2018. As of October 22, no amounts were drawn under the credit facility.

It was on October 3 that the social media giant announced its plan to raise up to $1 billion in an initial public offering. The company said it intends to apply to list its common stock under the ticker symbol 'TWTR'.

Twitter also said MoPub Inc., a mobile-focused advertising exchange that it agreed to buy on September 9, generated revenues of $6.52 million in the first half of 2013, compared to $2.69 million in fiscal 2012.

MoPub receives a fee from transactions completed by its customers and publishers on the exchange that it operates.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Packaged food producer ConAgra Brands Inc. reported Thursday higher net profit in its fourth quarter with margin strength. Net sales, meanwhile, declined from last year on weak volume. Looking ahead, for fiscal 2018, the company projects higher adjusted earnings and lower to flat sales. The company also reiterated its three-year fiscal 2020 financial algorithm. Best Buy announced Wednesday its plans to introduce Amazon Alexa and Google Home experiences to its 700 locations across the U.S. starting next month as part of its strategy of pushing smart home technology. A nationwide rollout will be complete by the end of the year. The electronics retailer will expand space at selected stores to better showcase how Amazon's Echo and Google Home interact.. So far this year, 23 novel drugs have already received FDA approval. Now let's take a look at the biotech stocks waiting to hear from the FDA in July.
comments powered by Disqus
Follow RTT